Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Feedzai’s new report reveals a lack of awareness of scams is putting many consumers at…
Major update adds new AI based tools, new Resolve FX, text based editing, speech to…
SOUTH SAN FRANCISCO, Calif., April 14, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
SOUTH SAN FRANCISCO, Calif., April 14, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
Arjun (Left) and Martin (Right) – Lab – 1 (Press) Arjun Bharioke (left) and Martin…
The partnership enables enterprises to secure, manage, and protect their brand across social networks AUSTIN,…
Consumers in Breckenridge, Vail and additional Colorado mountain towns can now work with a local…
DETROIT–(BUSINESS WIRE)–Bankjoy, a digital banking provider, today announced its integration with Fiserv Portico, a full-service…
LONDON, April 10, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
Khoros’s integration with Trustpilot saves brands time as they can manage reviews alongside everyday social…
New Application Supports Recruiters and Talent with Job Search and Apply Functionality BLOOMINGTON, Minn.–(BUSINESS WIRE)–#Avionte—Avionté,…
Launches Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution for Industry Leading Hemp/Cannabis Brands…
NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS)…
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
— Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated…
CAMBRIDGE, Mass., April 04, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the…
Helping the Council for Economic Education Build Life Skills Nationwide NEW YORK–(BUSINESS WIRE)–#CEE—Ray Dalio, New…
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…
Biosimilar Hyrimoz® (adalimumab) citrate-free high-concentration formulation (HCF) is now approved in the EU for use…